(CBUSAC) UBS(Lux)Fund Solutions – - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: LU1048316720

US Corporate Bonds, ETF

Description: CBUSAC UBS(Lux)Fund Solutions –

The UBS(Lux)Fund Solutions – Bloomberg US Liquid Corporates UCITS ETF(USD)A-acc is an exchange-traded fund (ETF) that tracks the Morningstar US Corp Bd TR USD index, providing investors with exposure to a diversified portfolio of US corporate bonds. As a USD Corporate Bond ETF, it aims to deliver returns that are in line with the overall performance of the US corporate bond market.

Given its investment objective, the fund is likely to be heavily influenced by changes in interest rates, credit spreads, and the overall economic environment. The funds assets under management (AUM) stand at $124.92M USD, indicating a relatively modest size compared to other ETFs in the same category. This could potentially impact its liquidity and trading costs.

From a technical analysis perspective, the funds price action suggests a relatively stable trend, with the short-term moving averages (SMA20 and SMA50) indicating a slight consolidation phase. The Average True Range (ATR) of 0.08 (0.59%) implies a moderate level of volatility. Considering the 52-week high and low prices of 14.26 and 13.23, respectively, the current price of 13.99 is closer to the lower end of the range, potentially indicating a buying opportunity.

Using a combination of technical and fundamental data, a forecast for the fund can be constructed. Assuming a stable economic environment and no significant changes in interest rates, the funds price is likely to remain within a narrow range. However, if credit spreads were to tighten, the fund could potentially benefit from the resulting increase in bond prices. Conversely, a widening of credit spreads could lead to a decline in the funds price. Based on the current technical indicators and fundamental data, a potential price target for the fund could be around 14.10-14.20, representing a 0.8-1.5% increase from the current price.

Its worth noting that the funds tracking error, fees, and other expenses can also impact its performance. Investors should carefully evaluate these factors, in addition to the funds overall investment objective and risk profile, before making any investment decisions.

Additional Sources for CBUSAC ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CBUSAC ETF Overview

Market Cap in USD 125m
Category USD Corporate Bond
TER 0.10%
IPO / Inception 2018-01-31

CBUSAC ETF Ratings

Growth Rating -9.99
Fundamental -
Dividend Rating 0.0
Rel. Strength 8.03
Analysts -
Fair Price Momentum 13.31 USD
Fair Price DCF -

CBUSAC Dividends

Currently no dividends paid

CBUSAC Growth Ratios

Growth Correlation 3m 70.7%
Growth Correlation 12m 38.6%
Growth Correlation 5y -46.6%
CAGR 5y -0.86%
CAGR/Max DD 5y -0.03
Sharpe Ratio 12m -0.79
Alpha 3.00
Beta -0.012
Volatility 7.74%
Current Volume 3.1k
Average Volume 20d 3.1k
What is the price of CBUSAC shares?
As of July 07, 2025, the stock is trading at USD 14.36 with a total of 3,144 shares traded.
Over the past week, the price has changed by +0.22%, over one month by +1.46%, over three months by +1.50% and over the past year by +5.85%.
Is UBS(Lux)Fund Solutions – a good stock to buy?
Neither. Based on ValueRay´s Analyses, UBS(Lux)Fund Solutions – is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -9.99 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CBUSAC is around 13.31 USD . This means that CBUSAC is currently overvalued and has a potential downside of -7.31%.
Is CBUSAC a buy, sell or hold?
UBS(Lux)Fund Solutions – has no consensus analysts rating.
What are the forecasts for CBUSAC share price target?
According to our own proprietary Forecast Model, CBUSAC UBS(Lux)Fund Solutions – will be worth about 14.4 in July 2026. The stock is currently trading at 14.36. This means that the stock has a potential upside of +0.14%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 14.4 0.1%